
Pionyr Immunotherapeutics
Discovers and develops first-in-class biologic drugs that fine-tune natural immune responses to increase immune defenses for diseases such as cancer, or to dampen immune responses in autoimmune diseases.
Employees
Enterprise value
$1.1—1.7b
Authorizing premium user...